Stem Cell Assay Patent Landscape Report 2024-2032 - Drug Discovery and Regenerative Medicine Drive Demand for Multi-Functional Stem Cell Assays Amid Rising Patent Activity
November 07, 2024 07:54 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Assay Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The stem cell assay market...
Stem Cell Therapy Market Analysis Report 2024-2029: iPSC Technology and Personalized Medicine Trends Drive Growth
November 06, 2024 05:12 ET
|
Research and Markets
Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy Market: Analysis By Type, By Stem Cell Source, By Application, By End User, By Region Size and Trends Forecast up to 2029" report has...
RTI Surgical Completes Acquisition of Collagen Solutions
November 01, 2024 08:38 ET
|
RTI Surgical
RTI Surgical Completes Acquisition of Collagen Solutions ALACHUA, Fla., November 1, 2024 – RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue...
RTI Surgical celebrates expansion of Tutoplast® Tissue Sterilization Process facility
October 30, 2024 07:17 ET
|
RTI Surgical
Ribbon-cutting ceremony to take place today, in Alachua, Florida ALACHUA, Fla., October 30, 2024; RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue...
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
October 27, 2024 15:10 ET
|
Longeveron
Longeveron reports positive long-term transplant-free survival (100% survival) data from a multi-year study in Hypoplastic Left Heart Syndrome (HLHS)
Genome Editing / Genome Engineering Strategic Research Report 2024-2030: Growing Role of Genome Editing in Personalized Medicine and Therapeutic Development Bodes Well for the Market
October 24, 2024 09:33 ET
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Genome Editing / Genome Engineering - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Cell Therapy Collaboration and Licensing Deals Report 2016-2024: A Comprehensive Listing of 910 Cell Therapy Deals by Company A-Z, Deal Type and Therapy Area
October 23, 2024 12:24 ET
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Cell Therapy Collaboration and...
NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA
October 23, 2024 02:56 ET
|
NurExone Biologic Inc
NurExone’s Groundbreaking Exosome Therapies to be Showcased at Fall U.S. Conferences
Pioneering Technological Developments Propel Regenerative Medicine Forward
October 22, 2024 04:01 ET
|
Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Technological Advances in Regenerative Medicine" report has been added to ResearchAndMarkets.com's offering. Pioneering Technological Developments...
Synthetic Biology Focused Insights Report 2024: A $59.91 Billion Market by 2029, Driven by Rising Use in Multiplexed Diagnostics and Therapeutic Genome Editing
October 16, 2024 10:41 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Synthetic Biology Market was...